Latest filing published 13 Jan 2026 for Praxis Precision Medicines, Inc., €82k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Lauren Mastrocola: trading record in brief
Lauren Mastrocola (senior executive) discloses dealings in Praxis Precision Medicines, Inc. to SEC (Form 4). Between 2 November 2020 and 12 January 2026, the trades on record add up to 31 filings.
The open-market side counts 1 purchase for €5,476 alongside 3 sales for €2.7M. Taken together, the sales exceed the purchases by €2.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 18 share grants and 9 option exercises.
The latest filing, published on 13 January 2026, reports a share grant of €82k in Praxis Precision Medicines, Inc. The clock since the last published purchase (21 June 2022) now reads 1,601 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lauren Mastrocola
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 344 shares@ US$275.7419.1% of flowCommon StockSEC:0001827639-26-000005:0
- 3,750 shares0Common StockSEC:0001689548-26-000014:0
- 35 shares@ US$292.632.0% of flowCommon StockSEC:0001827639-26-000002:0
- 1,047 shares@ US$49.5013.3% of flowCommon StockSEC:0001104659-25-115098:0
- 40 shares@ US$85.401.1% of flowCommon StockSEC:0001689548-25-000026:0
- 5,000 shares0Common StockSEC:0001689548-25-000016:0
- 35 shares@ US$77.520.9% of flowCommon StockSEC:0001689548-25-000007:0
- 294 shares@ US$37.403.6% of flowCommon StockSEC:0001104659-24-120748:0
- 4,374 shares@ US$56.9480.6% of flowCommon StockSEC:0001104659-24-119843:0
- 4,500 shares0Common StockSEC:0001104659-24-084504:0
- 48 shares@ US$44.650.7% of flowCommon StockSEC:0001689548-24-000027:0
- 35 shares@ US$25.190.3% of flowCommon StockSEC:0001689548-24-000005:0
- 711 shares@ US$3.940.9% of flowCommon StockSEC:0001689548-23-000048:0
- 520 shares@ US$2.520.4% of flowCommon StockSEC:0001689548-23-000006:0
- 3,000 shares@ US$1.9250.0001% mcap16.2% of flowCommon StockSEC:0001689548-22-000082:0Canonical exit: 14 Sept 2022 (T+90)
- 2,557 shares@ US$8.7985.1% of flowCommon StockSEC:0001689548-22-000046:0
- 584 shares@ US$12.851.5% of flowCommon StockSEC:0001689548-22-000005:0
- 6,000 shares0Common StockSEC:0001104659-22-003158:0
18 of 18 declarations
